Skip to main content
Drug bottle and Pill

Compare Nayzilam vs. Fycompa

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Nayzilam (midazolam) and Fycompa (perampanel) are both medications used to treat seizures, but they have some key differences. Nayzilam is a benzodiazepine nasal spray used for quick relief during seizure attacks in people 12 years and older. It works by slowing down brain activity and is only available as a brand-name medication. On the other hand, Fycompa is an antiepileptic taken orally, either as a liquid or tablet, and is used for long-term control of partial-onset seizures in people 4 years and older and generalized tonic-clonic seizures in people 12 years and older. Fycompa is also only available as a brand-name medication. While Nayzilam is used on an as-needed basis for immediate seizure control, Fycompa is taken once daily to prevent seizures. Both medications can cause drowsiness and have risks of misuse and dependence, but Fycompa also has a higher risk of mood changes and weight gain. Additionally, Nayzilam is a Schedule IV controlled substance, whereas Fycompa is a Schedule III controlled substance, indicating a higher potential for misuse with Fycompa.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.